Kinetic Properties of Erythrocyte Phosphofructokinase in Patients with Type VII Glycogenosis from Two Families--close Similarity to Liver Type Phosphofructokinase

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 1984 Jan 1

PMID 6239061

Citations 1

Authors

T Shimizu

N Kono

I Mineo

S Sumi

K Nonaka

S Tarui

W KOYAMA

Affiliations

Soon will be listed here.

Abstract

The kinetic properties of phosphofructokinases (PFKs) from normal human liver, muscle and erythrocytes, and from erythrocytes of two unrelated patients with type VII glycogenosis (muscle PFK deficiency, McKusick 23280) were analysed in this study. Sensitivity to inhibition by ATP and to inhibition by 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate and citrate were quite different for muscle and liver PFKs. The kinetic characteristics of normal erythrocyte PFK were intermediate between those of muscle and liver PFKs. The kinetic constants of erythrocyte PFK of a patient in one family were indistinguishable from those in the other family. In addition, kinetic behaviour of residual PFK activity in erythrocytes from patients in the two families were quite similar to those of normal liver PFK. These results of kinetic analyses provide convincing evidence for the concept that normal erythrocyte PFK consists of muscle and liver type subunits. Residual erythrocyte PFK activity in type VII glycogenosis is thus concluded to reflect the activity of liver type PFK existing in patient's erythrocytes.

Citing Articles

Characterization of phosphofructokinase-deficient canine erythrocytes.

Harvey J, Pate M, Mhaskar Y, Dunaway G J Inherit Metab Dis. 1992; 15(5):747-59.

PMID: 1434514 DOI: 10.1007/BF01800017.

References

Kono N, Kuwajima M, Tarui S . Alteration of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase. Diabetes. 1981; 30(4):346-53. DOI: 10.2337/diab.30.4.346. View

Tarui S, Okuno G, Ikura Y, Tanaka T, Suda M, Nishikawa M . PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. Biochem Biophys Res Commun. 1965; 19:517-23. DOI: 10.1016/0006-291x(65)90156-7. View

Uyeda K . Phosphofructokinase. Adv Enzymol Relat Areas Mol Biol. 1979; 48:193-244. DOI: 10.1002/9780470122938.ch4. View

Rose I, WARMS J . Glucose- and mannose-1,6-P2 as activators of phosphofructokinase in red blood cells. Biochem Biophys Res Commun. 1974; 59(4):1333-40. DOI: 10.1016/0006-291x(74)90460-4. View

HERS H, Van Schaftingen E . Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J. 1982; 206(1):1-12. PMC: 1158542. DOI: 10.1042/bj2060001. View

Koster J, Slee R, Van Berkel T . Isoenzymes of human phosphofructokinase. Clin Chim Acta. 1980; 103(2):169-73. DOI: 10.1016/0009-8981(80)90210-7. View

Zenella A, Mariani M, Meola G, Fagnani F, Sirchia G . Phosphofructokinase (PFK) deficiency due to a catalytically inactive mutant M-type subunit. Am J Hematol. 1982; 12(3):215-25. DOI: 10.1002/ajh.2830120303. View

Kono N, Uyeda K, Oliver R . Chicken liver phosphofructokinase. I. Crystallization and physicochemical properties. J Biol Chem. 1973; 248(24):8592-602. View

Tarui S, Kono N, Uyeda K . Purification and properties of rabbit erythrocyte phosphofructokinase. J Biol Chem. 1972; 247(4):1138-45. View

10.

Uyeda K, Furuya E, Luby L . The effect of natural and synthetic D-fructose 2,6-bisphosphate on the regulatory kinetic properties of liver and muscle phosphofructokinases. J Biol Chem. 1981; 256(16):8394-9. View

11.

Vora S . Isozymes of phosphofructokinase. Isozymes Curr Top Biol Med Res. 1982; 6:119-67. View

12.

Kahn A, Meienhofer M, Cottreau D, Lagrange J, DREYFUS J . Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues. Hum Genet. 1979; 48(1):93-108. DOI: 10.1007/BF00273280. View

13.

Layzer R, Rowland L, Bank W . Physical and kinetic properties of human phosphofructokinase from skeletal muscle and erythrocytes. J Biol Chem. 1969; 244(14):3823-31. View

14.

Beutler E, West C, Blume K . The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976; 88(2):328-33. View

15.

Vora S, Corash L, Engel W, Durham S, Seaman C, Piomelli S . The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy. Blood. 1980; 55(4):629-35. View

16.

Tarui S, Kono N, Nasu T, Nishikawa M . Enzymatic basis for the coexistence of myopathy and hemolytic disease in inherited muscle phosphofructokinase deficiency. Biochem Biophys Res Commun. 1969; 34(1):77-83. DOI: 10.1016/0006-291x(69)90531-2. View